Global Over The Counter (OTC) Testing Industry

Global Over The Counter (OTC) Testing Industry

  • April 2021 •
  • 183 pages •
  • Report ID: 6032415 •
  • Format: PDF
Abstract:
- Global Over The Counter (OTC) Testing Market to Reach $27 Billion by 2027
- Amid the COVID-19 crisis, the global market for Over The Counter (OTC) Testing estimated at US$14.2 Billion in the year 2020, is projected to reach a revised size of US$27 Billion by 2027, growing at a CAGR of 9.6% over the analysis period 2020-2027. Glucose Monitoring Tests, one of the segments analyzed in the report, is projected to record a 9.5% CAGR and reach US$8.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Pregnancy & Fertility Tests segment is readjusted to a revised 10.2% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $4.2 Billion, While China is Forecast to Grow at 9% CAGR
- The Over The Counter (OTC) Testing market in the U.S. is estimated at US$4.2 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$4.7 Billion by the year 2027 trailing a CAGR of 9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.9% and 7.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7.8% CAGR.
- Infectious Disease Tests Segment to Record 10.8% CAGR
- In the global Infectious Disease Tests segment, USA, Canada, Japan, China and Europe will drive the 10.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.9 Billion in the year 2020 will reach a projected size of US$3.9 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$3.1 Billion by the year 2027.

- Select Competitors (Total 33 Featured) -
  • Abbott Laboratories
  • AccuBioTech
  • ACON Laboratories
  • bioLytical Laboratories
  • i-Health Lab
  • LabStyle Innovations
  • NOWDiagnostics Company
  • OraSure Technologies
  • Roche Diagnostics
  • SD Biosensor
  • Sinocare